PATENT CLAIM ANALYSIS

Application Number: 16018496
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The present inventions include a method of inhibiting COMT enzyme in a subject as well as compounds of formula I, or a pharmaceutically acceptable salt thereof, that are useful in the treatment of various disorders mediated by COMT, including Parkinson's disease and/or schizophrenia.

Claim (Index 11):
The method according to  claim 9 , wherein:\n R 2  and R 3  are independently selected from any of the groups as defined for R 1 ; or R 2  and R 3  may together form a 3-10 membered monocyclic, bicyclic or spirocyclic nitrogen-containing ring system that contains 0-3 additional heteroatoms selected from oxygen (O), nitrogen (N), and sulfur (S), and which may be further substituted with one or more groups selected from halogen, C\u2261N, CF 3 , OH, C 1 -C 4  alkyl or C 2 -C 4  alkenyl, C 3 -C 6  cycloalkyl, alkoxy, nitro, amino, C 1 -C 4  alkoxycarbonyl, acyl, C 1 -C 4  alkylamino, oxo, SO 2 CH 3 , aryl, aralkyl, heterocyclyl, heteroaryl and heteroarylalkyl.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.23077
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15011353', '15011365', '15458534', '11015348', '14097808']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.798971280678686
- 35 USC 102 Novelty (BERT): 0.6067501604074502
- Combined Prediction Score: 0.7797491686515624
- Mean Citation Score: 363.848216
- Max Citation Score: 524.0887
- Similarity Product: 482.2028158280015

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test